{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:53:52Z","timestamp":1790970832005,"version":"4.1.0"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Upper limb lymphedema is a common complication after breast cancer surgery and may substantially impair upper limb function and quality of life. In clinical rehabilitation practice, external application of Sizi Powder combined with TDP therapy has been used as an adjunctive intervention; however, the available clinical evidence remains limited. This study aimed to evaluate the efficacy and safety of Sizi Powder external application combined with TDP therapy in patients with upper limb lymphedema after breast cancer surgery. This single-center retrospective cohort study included 86 patients with unilateral upper limb lymphedema after breast cancer surgery. According to the treatment received in routine clinical practice, patients were assigned to either a combination group treated with Sizi Powder external application plus TDP therapy (n\u2005=\u200544) or a control group receiving conventional rehabilitation management alone (n\u2005=\u200542). Outcome measures included changes in arm circumference difference, symptom scores, upper limb functional indicators, overall treatment response, and treatment-related adverse events. Multivariable logistic regression analysis was further performed to identify factors associated with clinical improvement. Both groups showed improvement after treatment, whereas the combination group demonstrated greater reductions in arm circumference difference at the wrist, 10\u2009cm below the elbow, the elbow, and 10\u2009cm above the elbow. Posttreatment swelling, pain, and heaviness scores were significantly lower in the combination group than in the control group. In addition, shoulder flexion, shoulder abduction, and DASH score improved more markedly in the combination group. Although the overall response rate was higher in the combination group than in the control group, the between-group difference did not reach statistical significance. Adverse events were mild and infrequent in both groups, and no serious treatment-related adverse events were observed. After adjustment for selected baseline covariates, combination treatment remained significantly associated with clinical improvement. Sizi Powder external application combined with TDP therapy may be a safe and beneficial adjunctive intervention for patients with upper limb lymphedema after breast cancer surgery, particularly in reducing swelling, alleviating symptom burden, and improving selected functional outcomes. Larger prospective studies are warranted to further confirm these findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050648","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:28Z","timestamp":1790967688000},"page":"e50648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Clinical effects of Sizi Powder external application combined with TDP therapy for upper limb lymphedema after breast cancer surgery"],"prefix":"10.1097","volume":"105","author":[{"given":"Juan","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wu\u2019han, Hubei, China"},{"name":"Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Department of Nursing, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wu\u2019han, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wu\u2019han, Hubei, China"},{"name":"Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5261-1235","authenticated-orcid":false,"given":"Huili","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"},{"name":"Department of Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wu\u2019han, Hubei, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261002","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"R2-20261002","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.19.02896","article-title":"Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment.","volume":"38","author":"McLaughlin","year":"2020","journal-title":"J Clin Oncol"},{"key":"R3-20261002","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","article-title":"Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: part 1: definitions, assessments, education, and future directions.","volume":"24","author":"McLaughlin","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"R4-20261002","first-page":"133","article-title":"The diagnosis and treatment of peripheral lymphedema: 2023 consensus document of the International Society of Lymphology.","volume":"56","year":"2023","journal-title":"Lymphology"},{"key":"R5-20261002","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","article-title":"The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment.","volume":"7","author":"J\u00f8rgensen","year":"2021","journal-title":"npj Breast Cancer"},{"key":"R6-20261002","first-page":"4875","article-title":"Current treatments for breast cancer-related lymphoedema: a systematic review.","volume":"17","author":"Li","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"R7-20261002","doi-asserted-by":"crossref","first-page":"e664","DOI":"10.1016\/j.clbc.2022.01.013","article-title":"Manual lymphatic drainage for breast cancer-related lymphedema: a systematic review and meta-analysis of randomized controlled trials.","volume":"22","author":"Lin","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"R8-20261002","first-page":"3593","article-title":"Resistance exercise and breast cancer-related lymphedema-a systematic review update and meta-analysis.","volume":"28","author":"Hasenoehrl","year":"2020","journal-title":"Support Care Cancer"},{"key":"R9-20261002","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1249\/MSS.0000000000002918","article-title":"The effect of exercise for the prevention and treatment of cancer-related lymphedema: a systematic review and meta-analysis.","volume":"54","author":"Hayes","year":"2022","journal-title":"Med Sci Sports Exerc"},{"key":"R10-20261002","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.breast.2017.09.006","article-title":"Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up.","volume":"36","author":"Pereira","year":"2017","journal-title":"Breast"},{"key":"R11-20261002","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ptj\/pzaa087","article-title":"Interventions for breast cancer-related lymphedema: clinical practice guideline from the academy of oncologic physical therapy of APTA.","volume":"100","author":"Davies","year":"2020","journal-title":"Phys Ther"},{"key":"R12-20261002","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1200\/JCO.21.01681","article-title":"Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and meta-analysis.","volume":"40","author":"Rafn","year":"2022","journal-title":"j Clin Oncol"},{"key":"R13-20261002","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.3390\/cancers14236016","article-title":"Early referral for breast-cancer-related lymphedema: do we follow the evidence? A two-year prospective multicenter cohort study.","volume":"14","author":"Hendrickx","year":"2022","journal-title":"Cancers (Basel)"},{"key":"R14-20261002","doi-asserted-by":"crossref","first-page":"102441","DOI":"10.1016\/j.eclinm.2024.102441","article-title":"Multinational Association of Supportive Care in Cancer (MASCC) clinical practice guidance for the prevention of breast cancer-related arm lymphoedema (BCRAL): international Delphi consensus-based recommendations.","volume":"68","author":"Wong","year":"2024","journal-title":"EClinicalMedicine"},{"key":"R15-20261002","first-page":"1081","article-title":"Implementing a prospective surveillance and early intervention model of care for breast cancer-related lymphedema into clinical practice: application of the RE-AIM framework.","volume":"29","author":"Koelmeyer","year":"2021","journal-title":"Support Care Cancer"},{"key":"R16-20261002","doi-asserted-by":"crossref","first-page":"102124","DOI":"10.1016\/j.suronc.2024.102124","article-title":"Breast cancer-related lymphedema: a critical review on recent progress.","volume":"56","author":"Sharifi","year":"2024","journal-title":"Surg Oncol"},{"key":"R17-20261002","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.31557\/APJCP.2023.24.7.2225","article-title":"Complete decongestive therapy effect on breast cancer related to lymphedema: a systemic review and meta-analysis of randomized controlled trials.","volume":"24","author":"Shamoun","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"key":"R18-20261002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s12032-024-02421-6","article-title":"Effectiveness of complete decongestive therapy for upper extremity breast cancer-related lymphedema: a review of systematic reviews.","volume":"41","author":"Gilchrist","year":"2024","journal-title":"Med Oncol"},{"key":"R19-20261002","first-page":"568","article-title":"Evidence for the clinical effectiveness of decongestive lymphoedema treatment for breast cancer-related arm lymphoedema, a systematic review.","volume":"32","author":"Jeffs","year":"2024","journal-title":"Support Care Cancer"},{"key":"R20-20261002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1089\/lrb.2022.0090","article-title":"The appraisal of clinical practice guidelines for breast cancer-related lymphedema.","volume":"21","author":"Dolgoy","year":"2023","journal-title":"Lymphat Res Biol"},{"key":"R21-20261002","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12609-020-00376-x","article-title":"Psychosocial issues associated with breast cancer-related lymphedema: a literature review.","volume":"12","author":"Eaton","year":"2020","journal-title":"Curr Breast Cancer Rep"},{"key":"R22-20261002","first-page":"e13440","article-title":"Self-reported signs and symptoms of secondary upper limb lymphoedema related to breast cancer treatment: systematic review.","volume":"30","author":"Gursen","year":"2021","journal-title":"Eur J Cancer Care (Engl)"},{"key":"R23-20261002","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1038\/s41598-021-89055-0","article-title":"Self-reported symptoms of arm lymphedema and health-related quality of life among female breast cancer survivors.","volume":"11","author":"Togawa","year":"2021","journal-title":"Sci Rep"},{"key":"R24-20261002","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11764-022-01262-4","article-title":"Patient education for breast cancer-related lymphedema: a systematic review.","volume":"17","author":"Perdomo","year":"2023","journal-title":"J Cancer Surviv"},{"key":"R25-20261002","first-page":"18","article-title":"Risk factors of unilateral breast cancer-related lymphedema: an updated systematic review and meta-analysis of 84 cohort studies.","volume":"31","author":"Shen","year":"2022","journal-title":"Support Care Cancer"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:01:31Z","timestamp":1790967691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050648"}},"subtitle":["A retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":25,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050648","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"2026-04-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}